Publicaciones (92) Publicaciones de JOSÉ MANUEL ZUBELDIA ORTUÑO

2024

  1. Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing

    Journal of Asthma, Vol. 61, Núm. 1, pp. 69-71

2023

  1. Oral Immunotherapy and Risk of Eosinophilic Esophagitis in Children: 15 Years' Experience

    Journal of pediatric gastroenterology and nutrition, Vol. 76, Núm. 1, pp. 53-58

2022

  1. Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract

    Journal of Investigational Allergology and Clinical Immunology

  2. The Natural Course of Adult-Onset Food Protein-Induced Enterocolitis Syndrome

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 2986-2992

2021

  1. El libro de las enfermedades alérgicas ed. lit.

    Fundación BBVA

  2. IGF-1 Haploinsufficiency Causes Age-Related Chronic Cochlear Inflammation and Increases Noise-Induced Hearing Loss

    Cells, Vol. 10, Núm. 7

  3. Mecanismos de las reacciones alérgicas

    El libro de las enfermedades alérgicas (Fundación BBVA), pp. 49-60

  4. Non-ige-mediated gastrointestinal food protein-induced allergic disorders. Clinical perspectives and analytical approaches

    Foods, Vol. 10, Núm. 11

  5. Poor prognosis of food protein–induced enterocolitis syndrome to fish

    Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 560-565

  6. Relevant features of adult-onset food protein–induced enterocolitis syndrome

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 4, pp. 1759-1760.e1

  7. Safety of new mrna vaccines against covid-19 in severely allergic patients

    Journal of Investigational Allergology and Clinical Immunology

  8. The applications of eHealth technologies in the management of asthma and allergic diseases

    Clinical and Translational Allergy, Vol. 11, Núm. 7

2020

  1. Drug challenge tests with general anesthetics: Predictive value of skin tests

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 2, pp. 101-107

  2. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

    The Lancet Child and Adolescent Health, Vol. 4, Núm. 10, pp. 728-739

2019

  1. Adjuvants in allergen-specific immunotherapy: Modulating and enhancing the immune response

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 2, pp. 103-111

  2. Delayed hypersensitivity reaction to lenalidomide: 2 different clinical patterns in the same patient

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 4, pp. 309-311

  3. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1

  4. Is self-injectable epinephrine being used by children with food allergy?

    Journal of Investigational Allergology and Clinical Immunology

  5. Oral food challenge in food protein-induced enterocolitis syndrome by fish: Is there any room for improvement?

    International Archives of Allergy and Immunology, Vol. 179, Núm. 3, pp. 215-220

  6. Survey of opinion of Spanish physicians on the role of eosinophils in asthma and other diseases

    Journal of Investigational Allergology and Clinical Immunology